<DOC>
	<DOCNO>NCT00623116</DOCNO>
	<brief_summary>Objective characterize epidemiology , clinical genetic feature Kallmann syndrome Finland .</brief_summary>
	<brief_title>A Study Characterize Epidemiology , Clinical Genetic Features Kallmann Syndrome Finland</brief_title>
	<detailed_description>Kallmann syndrome comprise idiopathic hypogonadotropic hypogonadism anosmia ( inability smell ) . Associated phenotype may include cryptorchidism , microphallus , bone deformation , mirror movement , hear loss infertility . Objective characterize epidemiology , clinical genetic feature Kallmann syndrome Finland .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Kallmann Syndrome</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Estrone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estropipate</mesh_term>
	<criteria>Kallmann syndrome Age 15 yr Severe mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Kallmann Syndrome</keyword>
	<keyword>hypogonadotropic hypogonadism</keyword>
</DOC>